The BioNTech SE (BNTX) gross profit margin is 84.3%, compared to the industry median of 64.9% and the 5-year historical average of 21.7%.
The BioNTech SE (BNTX) operating income margin is (10.4%), compared to the industry median of (879.7%)) and the 5-year historical average of 0.3%.
The BioNTech SE (BNTX) Free Cash Flow margin is 32.4%, compared to the industry median of (720.0%) and the 5-year historical average of (3.8%).
The BioNTech SE (BNTX) earnings quality is (312.1%), compared to the industry median of 83.4% and the 5-year historical average of 183.7%.